Evidence map›Paper›PMID 42667370›Full record

ArticleCalcified tissue international2026

Estimating the Extent of Missed Opportunities for Osteoporosis Treatment Before Hip Fracture Occurrence.

Gaetano Paride Arcidiacono, Marco Onofrio Torres, Chiara Ceolin, Mattia Giantin, Giovanni Tripepi, Valentina Camozzi, Anna Bertocco, Mor Peleg Falb, Martin Diogo, Francesca Guidolin and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Calcified tissue international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Gaetano Paride Arcidiacono *Department of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-0409-4449
Marco Onofrio Torres *Department of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0009-0004-1426-1452
Chiara CeolinDepartment of Medicine, University of Padova, Padova, Italy. chiara.ceolin.1@unipd.it.ORCID http://orcid.org/0000-0001-5064-1672
Mattia GiantinDepartment of Medicine, University of Padova, Padova, Italy.
Giovanni TripepiInstitute of Clinical Physiology (IFC), National Research Council (CNR), Reggio Calabria, Italy.ORCID http://orcid.org/0000-0002-3580-4602
Valentina CamozziEndocrinology Unit, Department of Medicine, Azienda Ospedale-Università Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-1634-951X
Anna BertoccoGeriatrics Division, Department of Medicine, Azienda Ospedale-Università Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-0652-1064
Mor Peleg FalbDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0009-0006-9413-3710
Martin DiogoDepartment of Medicine, University of Padova, Padova, Italy.
Francesca GuidolinDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0009-0005-4707-3615
Giacomo VoltanEndocrinology Unit, Department of Medicine, Azienda Ospedale-Università Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-3628-0492
Maria Grazia RodàDepartment of Orthopedics and Orthopedic Oncology, D.I.S.C.O.G. Department, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-5167-3219
Elisa PalaDepartment of Orthopedics and Orthopedic Oncology, D.I.S.C.O.G. Department, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-0210-5888
Andrea AngeliniDepartment of Orthopedics and Orthopedic Oncology, D.I.S.C.O.G. Department, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-8823-448X
Deris Gianni BoemoDepartment of Directional Hospital Management, Azienda Ospedale-Università Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-6239-029X
Maria Vittoria NesotiDepartment of Directional Hospital Management, Azienda Ospedale-Università Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-0778-7032
Elena CampelloDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-0377-3741
Pietro RuggieriDepartment of Orthopedics and Orthopedic Oncology, D.I.S.C.O.G. Department, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0001-9617-9882
Maria FusaroDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0001-9478-4851
Paolo SimioniDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-6744-383X
Giuseppe SergiDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0001-9757-856X
Sandro GianniniDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-0796-9749
Marina De RuiGeriatrics Division, Department of Medicine, Azienda Ospedale-Università Padova, Padova, Italy.ORCID http://orcid.org/0000-0003-4966-1312
Stefania SellaDepartment of Medicine, University of Padova, Padova, Italy.ORCID http://orcid.org/0000-0002-8645-4067
the Hip-POS working group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hip fractures (HF) are among the most serious consequences of osteoporosis. Many individuals who subsequently sustain a HF may already fulfill recognized criteria for fracture risk assessment, bone mineral density (BMD) evaluation, or anti-osteoporosis treatment before the event occurs, yet remain unidentified and untreated. We aimed to quantify these missed opportunities for osteoporosis management prior to fragility HF occurrence. We performed a cross-sectional analysis of 1,103 patients aged ≥ 50 years hospitalized for fragility HF and evaluated within a Fracture Liaison Service. Pre-fracture fracture risk was retrospectively estimated using FRAX

Indexed as

Bone Density Conservation AgentsHip FracturesOsteoporosisOsteoporotic FracturesAgedAged, 80 and overBone DensityCross-Sectional StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsUndertreatmentBone Density Conservation AgentsFracture Liaison serviceFracture preventionFracture risk assessmentHip fractureOsteoporosisTreatment gap

Identifiers

PMID42667370
PMCPMC13525934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.